HHLR ADVISORS, LTD.HHLR ADVISORS, LTD.

Institutional investor · Portfolio as of Q2 2019

SEC EDGAR SourceSEC Filings

Top Holdings43 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
ONCONC
ADR

BEIGENE LTD-ADR

4.4M$550.1M12.3%$136.92-9.47%
3 qtrssince 2018-Q4
Unchanged
0
JDJD
ADR

JD.COM INC-ADR

15.8M$477.1M10.7%$20.05+37.10%
3 qtrssince 2018-Q4
Increased
65
TALTAL
ADR

TAL ED GROUP

11.4M$434.7M9.7%$29.99+27.06%
3 qtrssince 2018-Q4
Unchanged
0
IQIQ
ADR

IQIYI INC

14.5M$299.6M6.7%$22.81-9.48%
3 qtrssince 2018-Q4
Increased
70
CBCBPODelisted

CHINA BIOLOGIC PRODS HLDGS I

2.8M$262.2M5.9%
3 qtrssince 2018-Q4
Unchanged
0
BABABABA
ADR

ALIBABA GROUP HOLDING-SP ADR

1.4M$239.2M5.3%$128.99+23.62%
3 qtrssince 2018-Q4
Unchanged
0

META PLATFORMS INC-CLASS A

1.2M$227.7M5.1%$165.53+15.79%
2 qtrssince 2019-Q1
Unchanged
0
1.7M$164.4M3.7%
Increased
91
PDDPDD
ADR

PDD HOLDINGS INC

7.2M$148.5M3.3%$21.79-5.31%
3 qtrssince 2018-Q4
Increased
91
WUBAWUBADelisted
ADR

58 COM INC

2.4M$146.8M3.3%
1 qtr
New
85
SESE
ADR

SEA LTD-ADR

4.3M$142.8M3.2%$23.52+41.24%
2 qtrssince 2019-Q1
Unchanged
0
BPMCBPMCDelisted

BLUEPRINT MEDICINES CORP

1.5M$141.4M3.2%
3 qtrssince 2018-Q4
Unchanged
0

MONDELEZ INTERNATIONAL INC-A

2.5M$137.3M3.1%$33.70+36.47%
3 qtrssince 2018-Q4
Decreased
0
BILIBILI
ADR

BILIBILI INC-SPONSORED ADR

8.1M$131.6M2.9%$16.18+0.55%
3 qtrssince 2018-Q4
Increased
84

Kyntra Bio, Inc.

2.7M$123.1M2.8%

TESLA INC

520,580$116.3M2.6%$14.900.00%
1 qtr
New
79
MLCOMLCO
ADR

MELCO RESORTS ENTERT ADR

4.4M$95.5M2.1%$21.86-3.02%
3 qtrssince 2018-Q4
Unchanged
0
ESGRESGRDelisted

ENSTAR GROUP LIMITED

543,487$94.7M2.1%
2 qtrssince 2019-Q1
Unchanged
0
APLSAPLSDelisted

APELLIS PHARMACEUTICALS INC

2.6M$65.4M1.5%$14.10+79.74%
3 qtrssince 2018-Q4
Unchanged
0

SNAP INC - A

4.5M$63.9M1.4%$14.300.00%
1 qtr
New
68
$4.5B
AUM
43
Positions
Q2 2019
Filing
Rating · 2.0
Quarterly Portfolio Change
+49%Q1'19$3.6B+25%Q2'19$4.5B
Activity profile
$ moved · Q2'19
New58%Increased41%Decreased2%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.1 quarters
<1Q21%1-4Q70%1-2Y0%2Y+9%

HHLR ADVISORS, LTD. manages $4.5B across 43 positions as of Q2 2019. Top holdings: ONC (12.3%), JD (10.7%), TAL (9.7%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2/5.0.

Q2 2019 Summary

Active quarter - 13 new positions, 0 exits, 6 increased. Top move: PDD (INCREASED, conviction 91). Portfolio: $4.5B across 43 positions.

Top holdings by portfolio weight

Total AUM$4B
ONC12.30%
JD10.67%
TAL9.72%
IQ6.70%
CBPO5.86%
BABA5.35%
META5.09%
NEW ORIENTAL3.68%
PDD3.32%
WUBA3.28%
Other3.19%

Portfolio allocation by GICS sector

Sectors6
Consumer Cyclical28.66%
Healthcare20.39%
Unknown18.80%
Communication Services18.36%
Consumer Defensive13.33%
Technology0.46%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Consumer Cyclical, Healthcare, Unknown
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track RecordNo data
Conviction42
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used